FDA approves Exxua for depression treatment after multiple rejections over more than two decades 

The U.S. Food and Drug Administration (FDA) on Thursday approved the medication Exxua to treat major depressive disorder – a significant step after a decades-long battle for approval. 

Exxua is unique for its ability to target the serotonin 1A receptor, which is a regulator of mood and emotion. In doing so, it avoids undesirable side effects that often come with drugs that treat anxiety and depression disorders, including sexual dysfunction and weight gain, according to the press release...